PTEN, encoding a lipid phosphatase, is a tumor suppressor gene and is mutated in various types of cancers. It is reported to regulate G1 to S phase transition of the cell cycle by influencing the expression, protein stability and subcellular location of cyclin D1. Here, we provide evidence that PTEN modulates the transcription and protein stability of cyclin D2. Targeted deletion of Pten in mouse embryonic fibroblasts (MEFs) endowed cells with greater potential to overcome G1 arrest than wild-type MEFs and led to the elevated expression of cyclin D2, which was suppressed by the introduction of PTEN. We further defined a pathway involving GSK3b and b-catenin/TCF in PTEN-mediated suppression of cyclin D2 transcription. LiCl, an inhibitor of GSK3b, abolished inhibitory effect of PTEN on cyclin D2 expression, and TCF members could directly bind to the promoter of cyclin D2 and regulate its transcription in a CREB-dependent manner. Our results indicate that the downregulation of cyclin D2 expression by PTEN is mediated by the GSK3b/b-catenin/TCF pathway in cooperation with CREB, and suggest a convergence from the PI-3 kinase/PTEN pathway and the Wnt pathway in modulation of cyclin D2 expression.
Introduction
Somatic mutations or deletion of the tumor suppressor gene PTEN have been identified in many types of tumors such as glioblastomas and endometrial, prostate, brain, breast, skin and kidney cancers Steck et al., 1997) . Germ-line mutations of PTEN cause three autosomal dominant disorders, Cowden disease, Lhermitte-Duclos disease and Bannayan-Zonana syndrome, all of which form benign tumors in a variety of tissues with increased risk for cancer development Nelen et al., 1997; Marsh et al., 1998) . PTEN is also essential for embryonic development: Its inactivation by gene targeted disruption in mouse resulted in early embryonic lethality, and Pten þ /À mice showed hyperplastic-dysplastic changes in many tissues (Di Cristofano et al., 1998) .
PTEN is a major regulator in the phosphatidylinositol 3 (PI 3 ) kinase (PI3K) pathway, acting as the PI 3 -phosphatase and negatively regulating the activity of the Ser/Thr kinase AKT/PKB (Maehama and Dixon, 1998; Stambolic et al., 1998) . AKT in turn modulates the activity of a number of downstream substrates such as glycogen synthase kinase 3b (GSK3b), BAD, caspase 9, and the forkhead transcription factors via phosphorylation (Datta et al., 1999) . GSK3b plays a vital role in the Wnt signaling pathway as a factor in a multi-component complex consisting of GSK3b, Axin, APC and others, and promotes the phosphorylation and therefore ubiquitination and proteosomal degradation of b-catenin. In this way, b-catenin is restricted from the nucleus and prevented from interacting with members of the TCF/LEF family and from activating the transcription of target genes (Aberle et al., 1997; Orford et al., 1997) .
PTEN influences cell survival and growth, and Pten À/À embryonic stem cells exhibited an increased growth rate. Reintroduction of PTEN into PTEN-null cells induced G1 cell cycle arrest (Sun et al., 1999; Persad et al., 2001) . PTEN regulates cell proliferation mainly through governing the G1-S transition. Progression of G1-S phase depends on the activities of G1 cyclin/cyclindependent kinase (CDK) complexes, and cyclin Ds are key regulators in the early-to-mid G1 phase (Sherr and Roberts, 1999) . Mice lacking cyclin Ds die in mid/late gestation, and cells without cyclin Ds exhibit reduced susceptibility to oncogenic transformation (Kozar et al., 2004) . In mammalian cells there are three types of cyclin Ds, D1, D2 and D3 (Xiong et al., 1992) . There is functional redundancy among these cyclin Ds, as it has been shown that cyclin D2 could substitute the function of cyclin D1 in mouse development (Carthon et al., 2005) . However, each cyclin D may also have distinct functions as they are often expressed mutually exclusively in different cell types (Wianny et al., 1998) .
The activity of cyclin Ds is tightly controlled. For instance, PTEN downregulates expression of cyclin D1 and inhibits its nuclear localization (Radu et al., 2003) . The PI3K pathway regulates cyclin D1 at the level of mRNA translation (Muise-Helmericks et al., 1998) , and GSK3b phosphorylates nuclear cyclin D1 and promotes its degradation (Diehl et al., 1998) .
Although many studies have demonstrated that cyclin D1 is an important target of PTEN, it is unclear whether and how PTEN influences the activity of other cyclin Ds. Several lines of evidence suggest that cyclin D2 could also be another key target of PTEN and PI3K and has unique physiological functions. Firstly, loss of PTEN occurs in a great portion of invasive germ cell tumors (Di Vizio et al., 2005) , while overexpression of cyclin D2 is frequently observed in germ cell tumors (Chaganti and Houldsworth, 2000) . Secondly, there seems to be a functionally negative correlation between cyclin D2 and PTEN in regulation of B-cell proliferation. Cyclin D2 is rate-limiting for the B-cell receptordependent proliferation of B cells, and proliferation of peripheral B cells is impaired in cyclin D2-deficient mice (Ciemerych et al., 2002; Mohamedali et al., 2003) . Interestingly, Pten-deficient B cells are hyperproliferative in response to mitogenic stimuli and exhibit a lower threshold for activation through the B-cell antigen receptor (Anzelon et al., 2003) . Furthermore, knockout of the PI3K p85a regulatory subunit resulted in loss of cyclin D2 induction in B lymphocytes (Piatelli et al., 2004) . Finally, genetic disruption of cyclin D2 expression in mice led to decreases in granule cell number and the absence of stellate interneurons in the cerebellum (Huard et al., 1999) , indicating the unique requirement of cyclin D2 for proliferation of the granule cell precursors and for proper differentiation of granule and stellate interneurons. PI3K-mediated signals are vital for proliferation and survival of cerebellar granule cells (Dudek et al., 1997) , and human patients with Lhermitte-Duclose disease (due to PTEN mutation) are also characterized by cerebellar hematomatous overgrowths (Ciemerych et al., 2002) .
In the present study, we provide evidence that PTEN regulates cyclin D2 protein stability and cyclin D2 expression at transcriptional level, and the latter regulation is mediated by GSK3b and b-catenin/TCF. Moreover, we show that CREB is indispensable for the transcriptional activation of cyclin D2.
Results

PTEN suppresses cyclin D2 expression
To examine the influence of PTEN on cyclin D expression, two sets of wild-type and Pten-null mouse embryonic fibroblasts (MEF) were used: Pten þ / þ and Pten À/À that were derived from the mice with conventional gene disruption; wild-type Pten-containing loxp and Pten-null Dloxp that were from the mice with conditional knockout (Sun et al., 1999; Lesche et al., 2002) . Reverse transcription-polymerase chain reaction (RT-PCR) was employed to analyse the levels of cylin D1, cyclin D2 and p21 CIP1 in these MEFs. As shown in Figure 1a , the cyclin D1 mRNA level was elevated in Pten-null cells, consistent with the early report that (Radu et al., 2003) . Interestingly, cyclin D2 was more significantly upregulated in Pten-null cells. In addition, the cyclin kinase inhibitor p21 CIP1 was downregulated in these cells. Furthermore, cyclin D2 protein levels in Pten-null cells were also apparently higher than those in wild-type MEFs as shown by immunoblotting (Figure 1b) . These data collectively suggest that PTEN suppresses cyclin D2 expression at both the mRNA level and the protein level. Consistent with a higher expression of cyclin D1 and D2, the kinase activity of CDK4 was also elevated in Pten-null cells (data not shown).
To confirm inhibition of cyclin D2 expression by PTEN, a 1600 base pair (bp) promoter fragment (upstream from the start codon ATG) of cyclin D2 was cloned from the mouse genome and constructed into the luciferase reporter pGL3 to generate À1600D2-luc. As shown in Figure 1c , reintroduction of PTEN into Pten-null MEFs significantly suppressed the cyclin D2 promoter-mediated luciferase expression. Furthermore, two phosphatase-defective mutants, PTEN(C124S) and PTEN(G129E), were unable to inhibit the promoter activity, suggesting that PTEN inhibited cyclin D2 by a phosphatase-dependent mechanism. PTEN also inhibited cyclin D2 promoter activity in murine precursor B cells BAF3 (Figure 1d) , in which the critical role of cyclin D2 in proliferation has already been demonstrated (Jena et al., 2002; Parada et al., 2001) . Similar data were obtained in NIH3T3 cells (Figure 1e ) and melanoma B16 cells (Figure 1f ), both of which express wild-type PTEN, and in PTEN-null glioblastoma U87 cells (data not shown), in which reintroduction of PTEN can cause growth arrest (Furnari et al., 1997) . These data together suggest that PTEN decreases cyclin D2 expression, and this suppression depends on its phosphatase activity.
PI3K pathway is involved in the suppression of cyclin D2 by PTEN PTEN mainly exerts its functions as a negative regulator of the PI3K pathway, so we attempted to address whether its suppression of cyclin D2 was mediated by the PI3K pathway. Treatment of LY294002, an inhibitor of PI3K, greatly reduced the activity of cyclin D2 promoter in Pten À/À MEFs (Figure 2a ), suggesting that PTEN regulated cyclin D2 through the PI3K pathway. Furthermore, treatment of LY294002 for 24 h decreased about 40% of the activity of cyclin D2 promoter (data not shown), and inhibited the endogenous cyclin D2 protein level in BAF3 cells (Figure 2b ). To examine the importance of cyclin D2 in the cell cycle, proliferation of BAF3 cells was analysed after treated with LY294002. LY294002 treatment resulted in the accumulation of more cells in the G1 phase ( Figure 2c ) and remarkable inhibition of cell growth ( Figure 2d ).
GSK3b functions downstream of PTEN in regulating cyclin D2
0 s transcription To investigate the mechanism involved in the suppression of cyclin D2 expression by PTEN, we screened PTEN-regulated candidate factors by analysing their effects on cyclin D2 promoter activity. GSK3b activity is known to be inhibited via phosphorylation by activated AKT in PTEN-null cells (Luo et al., 2003) . Interestingly, overexpression of GSK3b inhibited the expression of the cyclin D2 reporters in NIH3T3 cells (Figure 3a ), Ptennull MEFs and B16 cells (data not shown), and its kinase activity was required for this inhibition as the kinase-defective mutant of GSK3b, GSK3b(KM), had no effect. In addition, LiCl, an inhibitor of GSK3b, abolished PTEN repression on both cyclin D2 promoter ( Figure 3b ) and cyclin D1 promoter (data not shown). These results together suggest that GSK3b is involved in the PTEN suppression of cyclin D2 expression.
We further confirmed the suppression of cyclin D2 transcription by GSK3b in mouse NIH3T3 cells by RT-PCR. The serum-starved cells were treated with LiCl, 10% fetal bovine serum or both. The expression of cyclin D2 was stimulated by LiCl plus serum at 1 h, or by either alone at 3 h, while cyclin D1 was upregulated only by LiCl plus serum at 3 h (Figure 3c and d). These data strongly suggest that GSK3b plays an important role in modulating the expression of both cyclin D1 and D2, and in certain conditions cyclin D2 is more sensitive to GSK3b activity than cyclin D1. Rapid induction of cyclin D2 also indicates that it is a direct effect rather than a side effect of cell cycle changes caused by inhibition of GSK3b. 
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To delineate the responsive element in the cyclin D2 promoter, a series of deletions were made. As shown in Figure 3a , À352D2-Luc showed similar responsiveness to PTEN and GSK3b as the longest promoter (À1600D2-Luc), while further deletion to À300 bp diminished the reporter expression to the basal level, indicating that the responsive element is located in the region from À352 to À300 bp of the cyclin D2 promoter.
b-Catenin/TCF are involved in the regulation of cyclin D2 transcription by PTEN As GSK3b is a key regulator of Wnt signaling by controlling the activity of b-catenin/TCF transcription complex, we next asked whether the b-catenin/TCF pathway is involved in the regulation of cyclin D2 transcription by GSK3b. In Pten-null MEFs, overexpression of Axin, a scaffold protein that has an inhibitory effect on Wnt signaling by promoting bcatenin degradation, inhibited the activities of cyclin D1 and cylin D2 promoters (Figure 4a ). A dominant negative mutant of TCF4 (dnTCF4), which lacks the b-catenin interacting domain (Korinek et al., 1997) , exhibited an inhibitory effect (Figure 4a ). Moreover, in b-catenin-responsive HeLa cells, overexpression of b-catenin stimulated expression of À1600D2-Luc and À352D2-Luc in a dose-dependent way (Figure 4b ). Therefore, these data suggest that both b-catenin and TCF are involved in the transcriptional regulation of both cyclin D1 and cyclin D2.
We next examined whether TCF family members directly functioned in the transcriptional regulation of cyclin D2 through binding to its promoter. A prospective TCF-binding site was found between À339 and À332 bp in the cyclin D2 promoter (Figure 5a ), and the corresponding oligonucleotide was used for DNAbinding assay. As shown in Figure 4c , both HA-tagged TCF4 and LEF1 bound to this oligonucleotide, but HA-tagged activin type II receptor (ActRII) did not. Furthermore, chromatin immunoprecipitation assay also showed that TCF4 could directly bind to the cyclin D2 promoter in vivo (Figure 4d ).
To further confirm that b-catenin/TCF are involved in the repression of cyclin D2 transcription by PTEN and GSK3b, the prospective TCF-binding site in À352D2-Luc was mutated. The mutation abolished the inhibitory effect of GSK3b (Figure 5c ) on the resultant reporter À352D2-TCFm-Luc, whose activity and responsiveness to PTEN were also reduced (Figure 5b ), suggesting that this putative TCF-binding site is essential for PTEN suppression of cyclin D2 transcription. Furthermore, dnTCF4 could block the LiCl-induced activity of À352D2-Luc (Figure 4e) .
The above data suggest that PTEN suppression of cyclin D2 expression is via the GSK3b/b-catenin/TCF pathway. To directly test whether PTEN could affect TCF transcription activity, we examined the PTEN influence on the activity of a LEF-1-luciferase reporter, which contains classical LEF-1-binding sites (Hsu et al., 1998) . As shown in Figure 4f , exogenous expression of PTEN in Pten-null MEFs reduced the LEF-mediated (Figure 5a ), and previous studies have shown that CREB can bind to this CRE (Sicinski et al., 1996) . CREB is a substrate of GSK3b (Bullock and Habener, 1998) , and its binding site CRE was reported to be important in the activation of cyclin D2 transcription (Sicinski et al., 1996; White et al., 2006) . Mutation of the CRE (À352D2-CREm-Luc) dramatically decreased the overall activity of the cyclin D2 promoter, and the transcriptional inhibition by PTEN and GSK3b was also reduced (Figure 5b and c) , indicating an essential role of the CRE in TCF-mediated transcriptional activation of cyclin D2. To further verify the importance of the CRE, CREB(S119A), a CREB dominant negative mutant (Barton et al., 1996) , was used. CREB(S119A) inhibited the promoter activity of both cyclin D1 and cyclin D2 in Pten À/À MEFs (Figure 5d ) and interfered with the induction of cyclin D2 promoter activity by b-catenin in HeLa cells (Figure 5e ). However, À300D2-Luc, which retained the CRE but not the TCF-binding site, had low basal activity and poor responsiveness to PTEN and GSK3b (Figure 3a) . Together with the observation that TCF can bind to the cyclin D2 promoter and this binding is essential for PTEN-mediated suppression, these results suggest that the CRE is indispensable for cyclin D2 expression and that there may be a functional cooperation between CREB and TCF in regulation of cyclin D2 transcription.
Loss of PTEN results in stabilization of cyclin D2 protein
We further explored whether PTEN regulates cyclin D2 protein stability. MEFs were treated with cycloheximide to block protein synthesis, and the half-life of the endogenous cyclin D2 protein was examined with immunoblotting. As shown in Figure 6a (c) HEK293T cells expressing HA-ActRII (activin type II receptor), HA-TCF4 or HA-LEF1 were harvested at 48 h posttranfection, and the cell lysates incubated with the biotinylated TCF-binding site-containing oligonucleotide derived from the cyclin D2 promoter. DNA-bound proteins were analysed by anti-HA immunoblotting. (d) ChIP was performed with B16 cells transfected with Myc-TCF4. TCF4-DNA complexes were precipitated with anti-Myc antibody, and DNA purified from the complexes was subjected to PCR. The input DNA templates were from the cell lysates before immunoprecipitation. Specific cyclin D2 promoter primers were designed to cover the region from À454 to À99bp. b-Actin served as a negative control. (e) Pten À/À MEFs were transfected with the reporter À352D2-Luc (0.5 mg) together with empty vector or dnTCF4 (0.3mg) as indicated and treated with 30 mM LiCl for 10 h before harvested. (f) Pten À/À MEFs were transfected with LEF-Luciferase with or without PTEN. For reporter assay, the transfected cells were lysed for luciferase assay at 30 h post-transfection. Each experiment was performed in triplicate and the data represent the mean7s.d. of three independent experiments after normalized to Renilla activity.
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GSK3b was reported to regulate the protein stability of cyclin D1 (Diehl et al., 1998 ). Therefore, we tested whether LiCl treatment affects cyclin D2 protein turnover. Cells were treated with LiCl for 10 h and then with cycloheximide for up to 4 h. Cyclin D2 protein was detected by immunoblotting at indicated times. LiCl stabilized cyclin D2 protein both in wild-type MEFs (Figure 6b ) and BAF3 cells (Figure 6c ). Therefore, GSK3b may mediate the effect of PTEN on cyclin D2 at both the transcription level and the protein level.
Pten
À/À MEFs possess a greater potential to break G1 arrest As cyclin D2 is an important G1 cyclin, and its regulation by PTEN may contribute to PTEN's influence on the cell cycle. It has been shown that Pten À/À ES cells exhibit an increased growth rate and proliferate even in the absence of serum (Sun et al., 1999) . As loss of PTEN elevated the mRNA and protein levels of cyclin D2, we next examined whether loss of PTEN would lead to growth advantage or greater ability to overcome G1 arrest in Pten-null MEFs. By counting cell number at different time points after seeding the same amounts of cells, we found no obvious growth difference between Pten þ / þ and Pten À/À MEFs (data not shown). However, when stimulated by 10% serum after 36 h serum starvation, Pten À/À cells entered S phase more quickly than wild-type cells (Figure 7a ). Upon cell cycle re-entry, both cyclin D1 and cyclin D2 proteins were elevated more rapidly in Pten À/À cells than in wild-type MEFs (Figure 7b) .
We further examined the biological significance of the PTEN-mediated suppression of cyclin D2 with RNA interference. Retrovirus encoding siRNA to effectively knock down cyclin D2 expression was generated 
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W Huang et al ( Figure 7c , lower panel). After Pten À/À MEFs were infected with cyclin D2 siRNA-encoding virus, subconfluent cells were cultured in medium with 2% serum for 20 h, and then harvested for cell cycle analysis. Knockdown of cyclin D2 expression led to a constant higher percentage of the cells in the G1 phase compared to the cells infected with GFP siRNA virus (Figure 7c ). These data together indicate that loss of PTEN endows cells with greater potential to overcome the G1 arrest, which is at least partially contributed by the elevated level of cyclin D2.
Discussion
Regulation of cyclin D2 expression by PTEN PTEN is an important tumor suppressor gene whose product regulates the G1-S transition by influencing the expression of cyclin D1 and p27 KIP1 . In this study, we demonstrated that PTEN regulated the transcription and protein stability of another important G1 cyclincyclin D2. We further showed that the GSK3b/bcatenin/TCF pathway played a critical role in the regulation of cyclin D2 transcription by PTEN. GSK3b Suppression of cyclin D2 expression by PTEN W Huang et al inhibited the transcription of cyclin D2, and LiCl, a GSK3b inhibitor, upregulated cylin D2 expression. The activation of cyclin D2 expression required a nonclassical TCF-binding site and a neighboring CREBbinding site, mutation of either of them led to a reduced promoter activity. Furthermore, TCF family members TCF4 and LEF1 could directly bind to the cyclin D2 promoter.
The phenotypic analyses of single-cyclin knockout mice reveal that each of D type cyclins is sufficient to drive normal development of the majority of tissues (Ciemerych et al., 2002) . However, in mouse embryo and some organs of adult animals, different cyclin D shows distinct expression patterns, indicating individual cyclin D may have their specific functions. In the early stage of embryogenesis, cyclin D1 and cyclin D2 display opposite and specific expression patterns in the developing hindbrain (Wianny et al., 1998) . Furthermore, this exclusive expression pattern of cyclin Ds is also preserved in some organs of adult animals (Ravnik et al., 1995; Robker and Richards, 1998) . Thus, each of cyclin Ds may have distinct functions possibly by associating with tissue specific interactors (Ciemerych et al., 2002) . In this study, we showed that PTEN regulated not only the expression of cyclin D1 but also of cyclin D2. Both mRNA and protein levels of cyclin D2 are elevated in Pten-null MEFs, and reintroduction of PTEN downregulated the promoter activity of cyclin D2 in Pten À/À MEFs and U87 cells. Our data are consistent with the previous report that an active FoxO3a, an important downstream effector of PTEN, inhibited cyclin D2 in a colon carcinoma cell line (Schmidt et al., 2002) . PTEN was also found to reduce cyclin D3 expression in endometrial carcinomas cells (Zhu et al., 2001) . Therefore, PTEN is a general negative modulator for all the three types of cyclin D.
GSK3b and b-catenin are downstream effectors of PTEN PTEN is a negative regulator of the PI3K pathway. Loss of PTEN leads to higher activity of AKT, which modulates activities of multiple downstream factors via phosphorylation (Stiles et al., 2002) . AKT phosphorylates and inhibits GSK3b activity, thereby leading to the stabilization of b-catenin (Diehl et al., 1998) . Here, we demonstrated that PTEN and GSK3b repressed cyclin D2 transcription and that b-catenin/TCF Figure 7 Cyclin D2 contributes to the G1-S transition of the cell cycle. (a) Pten-null MEFs have greater potential to overcome G1 arrest. MEFs were synchronized by serum starvation for 36 h and refed with growth medium containing 10% FBS. The cells were harvested for FACS analysis at different time points. Serumstarved MEFs in the G1 phase were set to 100% and the Y-value represents the relative percentage of the cells in G1 phase. Each sample was performed in triplicate. (b) After the serum-starved cells were stimulated with FBS at indicated times, the cells were harvested for immunoblotting. b-Tubulin was used for loading control. Protein amount was quantitated and the data represent the mean7s.d. of three independent experiments (lower panel). (c) Knockdown of cyclin D2 retains more cells in G1 phase. Subconfluent MEFs infected with either retrovirus encoding GFP siRNA or cyclin D2 siRNA were cultured in the medium containing 2% FBS for 20 h. The cells were harvested for FACS analysis. Each sample was performed in triplicate, and the data were analysed with t-test (P ¼ 0.0025). Cyclin D2 expression was examined by RT-PCT (lower panels), and a-actin was used for loading control. (d) A working model depicting the pathway responsible for PTEN regulation of cyclin D2 expression. Downregulation by PTEN of cyclin D2 is mediated by the GSK3b/ b-catenin/TCF pathway which collaborates with CREB (see the text for the details).
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W Huang et al functioned downstream of GSK3b. b-Catenin was reported to regulate the expression of cyclin D2 via transcription factor Pitx2 which recruits CBP/p300 and b-catenin to the cyclin D2 promoter (between À810 and À547) (Kioussi et al., 2002) . Our data showed that TCF family members could directly bind to a prospective TCF-binding site between À352 and À300 in the cyclin D2 promoter. Mutation of this site resulted in loss of response to GSK3b and a significantly lower basal activity, indicating that this novel TCF-binding element is important for the transcription activation of cyclin D2. We found that Axin and a dominant negative TCF4 mutant significantly reduced the promoter activity of cyclin D2. Our data also showed that the LEFresponsive reporter activity was reduced by the reintroduction of PTEN. These data are consistent with the well-established signaling pathway (Figure 7d ): loss of PTEN results in an elevated activity of AKT, a decreased activity of GSK3b and consequently b-catenin accumulation and the activation of TCF-mediated transcription. It has been documented that in prostate cancers, PTEN inhibits b-catenin accumulation and b-catenin/TCF-mediated transcription, while activation of PI3K leads to the nuclear accumulation of b-catenin (Persad et al., 2001) . GSK3b may also negatively influence CREB activity as CREB was shown to be an in vitro substrate of GSK3b (Bullock and Habener, 1998) . Taken together, these results suggest that in certain types of cells, cross-talk between the PI3K pathway and the Wnt pathway regulates the transcription of cyclin D.
Collaboration of TCF and CREB in modulating cyclin D2 expression It has been demonstrated that b-catenin/TCF-mediated transcription relies on their cooperation with other factors, such as AP-1 and ETS (Tetsu and McCormick, 1999) . Our data showed that the CREB-binding sequence CRE was indispensable for the transcription of cyclin D2 regulated by b-catenin/TCF. CRE mutation (À352D2-CREm-Luc) resulted in a significantly reduced basal activity and poor responsiveness to PTEN and GSK3b. A dominant negative CREB mutant reduced the activity of the cyclin D2 promoter. These results suggest that the b-catenin/TCF transcriptional complex requires and collaborates with CREB via some unknown mechanism. Although their binding sites are in close proximity, the direct interaction between CREB and b-catenin/TCF complex could not be detected, even in the presence of CBP/p300 (data not shown). The importance of the CRE has been reported in b-cateninmediated transcriptional activation of several other genes, such as cyclin D1 and WISP-1 (Xu et al., 2000; Pradeep et al., 2004) .
PTEN negatively regulates cell proliferation. A previous study has demonstrated that Pten À/À ES cells exhibit an increased growth rate (Sun et al., 1999) . Consistent with it, our data showed that after serum starvation, Pten-null cells entered S phase more quickly than wild-type MEFs in the presence of 10% serum. We further investigated the biological significance of the regulation of cyclin D2 by PTEN. Knockdown of cyclin D2 expression by RNA interference in Pten-null MEFs resulted in a constant higher percentage of the cells in G1 phase. That the effect was not dramatic might be due to redundant functions of cyclin D1 and cyclin D2 in promoting the G1-S transition. Nevertheless, our results indicate the importance of the regulation of cyclin D2 by PTEN.
In summary, we have provided evidence that PTEN controls cell cycle progress not only via cyclin D1, p27 KIP1 , but also via cyclin D2. Our findings implicate that the regulation of cyclin D2 expression by PTEN may play a vital role in proliferation of certain types of cells where cyclin D2 is specifically expressed, such as in cerebellar granule neurons. Our data also suggest that overexpression of cyclin D2 may contribute to uncontrolled growth of PTEN-deficient cells, resulting in tumorigenesis.
Materials and methods
Cell lines, transfection and antibodies
Wild-type ( þ / þ and loxp) and Pten-null (À/À and Dloxp) MEFs, U87, HEK293T, NIH3T3, HeLa and B16 cells were cultured in Dulbecco's modified Eagle's medium (Invitrogen GIBCO, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS, Hyclone, Logan, UT, USA). BAF3 cells were maintained in RPMI 1640 medium (GIBCO) supplemented with 10% FBS and 10% WEHI cell-conditioned medium as a source of IL3. HEK293T, NIH3T3 and HeLa cells were transfected with calcium phosphate, MEF, U87 and B16 cells with LipofectAMINE (Invitrogen, Carlsbad, CA, USA), and BAF3 cells by electroporation. Anti-cyclin D2 antibody (sc-953) and anti-cyclin D1 antibody (sc-8396) were from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and anti-b-tubulin antibody from Sigma (St Louis, MO, USA).
Plasmid constructs PTEN and its mutants were described previously (Liliental et al., 2000) and subcloned into pCMV5. pCMV-HA-GSK3b (wild-type and kinase-defective mutant KM) and pCMV-HAAxin plasmids were gifts from Dr S-C Lin, cyclin D1 promoter reporters from Dr F McCormick and Dr Y Shang, dominant negative form of TCF4 from Dr H Clevers, and CREB(S119A) from Dr H Xu.
The cyclin D2 promoter (À1600D2) was cloned from mouse genomic DNA and this KpnI-XhoI fragment was inserted into pGL3 (Promega) to generate À1600D2-Luc. A series of cyclin D2 promoter deletions were generated with PCR from À1600D2-Luc using the following primers: forward,
0 . À352D2-TCFm-Luc and À352D2-CREm-Luc was constructed with PCR-based sitedirected mutagenesis using primers (À352D2-TCFm: 
FACS and cell cycle analysis
MEFs with 70% confluence were synchronized by serum starvation for 36 h and reseeded into 60 mm dishes. Cells were fixed in 70% cold ethanol, washed once with PBS, and incubated for 30 min at 41C in PBS containing 100 mg/ml of RNase A and 50 mg/ml of propidium iodide. Cells were subjected to a FACScan flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA) for cell cycle analysis.
Reverse transcription-polymerase chain reaction Total RNA was isolated using Trizol (Roche, Basel, Switzerland) reagent, and the genomic DNA was removed by DNase (Takara, Shiga, Japan). Two microgram RNA was reversetranscribed at 421C for 45 min in a 20 ml reaction mixture using the Reverse Transcription System (Promega, Madison, WI, USA). Expression levels of cyclin D1, cyclin D2, and a-actin were detected by semi-quantitative PCR with the following primers: cyclin D1, 5 0 -TCCCTTGACTGCCGAGAAG-3 0 (forward) and 5 0 -AGACCAGCCTCTTCCTCCAC-3 0 (reverse); cyclin D2, 5 0 -TGCATGTTCCTAGCTTCC-3 0 (forward) and 5 0 -CTCTTGACGGAACTGCTG-3 0 (reverse); a-actin, 5 0 -GGG TATGGAATCCTGTGGC-3 0 (forward) and 5 0 -AGTCCGCC TAGAAGCACTTG-3 0 (reverse).
Luciferase assay A dual luciferase reporter assay was performed whereby a promoter reporter and the control reporter (pRenilla) were cotransfected with other plasmids as indicated in the figure legends. Cells were seeded into 24-well plates, and transient transfection was performed when the cells reached about 50% confluence. The cells were lysed with passive lysis buffer (Promega) for luciferase assay at 30 h post-transfection. Luciferase activities were measured by a luminometer (Berthold Technologies) and normalized to Renilla activity. Experiments were repeated in triplicate.
DNA-binding assay HEK293T cells transfected with various plasmids were harvested at 48 h post-transfection. After washed with phosphate-buffered saline (PBS) twice, the cells were lysed in lysis buffer (100 mM KCl, 10 mM Hepes pH7.9, 10% glycerol, 5 mM MgCl 2 , 0.5% NP-40, 10 mM NaF, 20 mM sodium bglycerol phosphate, 1 mM DTT and protease inhibitors) and sonicated for 11 s continuously. The lysates were pre-cleaned with ImmunoPure streptavidin-agarose beads (Pierce) for 1 h at 41C and then incubated overnight with 10 mg poly(dI-dC) (Pierce) and 1 mg of biotinylated double-stranded probe containing the prospective TCF-binding site (the underlined sequence) (5 0 -GGGAAAGATTGAAAGGAGGGGAGGGA CGCTAGAGGAGGGGAGGAAAGGGGGAGG-3 0 ). DNAbound proteins were precipitated with streptavidin-agarose beads and analysed by immunoblotting.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) assay was performed the same as described previously (Shang et al., 2000) . Briefly, B16 cells expressing Myc-TCF4 were cross-linked with 1% formaldehyde at 48 h post-transfection, and the lysates were subjected to immunoprecipitation with anti-Myc antibody. The protein-bound DNA was purified using PCR purification kit (Qiagen) and analysed by PCR with the following primers: cyclin D2 forward (5 0 -GGATCGTGTTTGAAGTTTGG TC-3 0 ), and reverse (5 0 -CCTTTGGCTGAATGGGAGA-3 0 ); b-actin forward (5 0 -CTCTCTCGTGGCTAGTACC-3 0 ) and reverse (5 0 -TTCCCAATACTGTGTACTCTC-3 0 ).
Abbreviations
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